Barclays Has Lowered Expectations for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price objective cut by analysts at Barclays from $112.00 to $102.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s target price would suggest a potential upside of 4.43% from the company’s current price.

A number of other research firms also recently commented on ADUS. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Wednesday, February 25th. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Finally, Stephens lowered their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $133.22.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $97.67 on Wednesday. Addus HomeCare has a twelve month low of $94.86 and a twelve month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock has a fifty day simple moving average of $106.00 and a two-hundred day simple moving average of $111.21. The stock has a market capitalization of $1.82 billion, a price-to-earnings ratio of 18.75, a P/E/G ratio of 1.38 and a beta of 0.92.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 300 shares of the business’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $31,608.00. Following the transaction, the executive vice president directly owned 9,444 shares in the company, valued at $995,019.84. The trade was a 3.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Roberton James Stevenson sold 284 shares of the stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $29,922.24. Following the completion of the sale, the executive vice president owned 14,030 shares of the company’s stock, valued at approximately $1,478,200.80. This trade represents a 1.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 16,610 shares of company stock worth $1,768,970. 4.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

Institutional investors have recently bought and sold shares of the stock. TimesSquare Capital Management LLC lifted its stake in shares of Addus HomeCare by 6.2% during the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock worth $49,361,000 after buying an additional 24,301 shares during the period. Russell Investments Group Ltd. increased its position in shares of Addus HomeCare by 10.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock valued at $6,439,000 after acquiring an additional 5,110 shares during the period. Public Sector Pension Investment Board increased its position in shares of Addus HomeCare by 14.4% in the 3rd quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after acquiring an additional 8,893 shares during the period. Creative Planning raised its stake in Addus HomeCare by 150.9% in the 2nd quarter. Creative Planning now owns 7,024 shares of the company’s stock worth $809,000 after acquiring an additional 4,224 shares during the last quarter. Finally, Tributary Capital Management LLC lifted its position in Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after acquiring an additional 212,192 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.